Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pengxun Han

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Translational Research|July 18, 2019
Artemether improves type 1 diabetic kidney disease by regulating mitochondrial functionYao Wang, Pengxun Han, Menghua Wang, et al.
Plos One|April 29, 2026
Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolismQike Fu, Jiaxin Li, Xiufen Gu, et al.
Kidney & Blood Pressure Research|September 12, 2013
Lisinopril protects against the adriamycin nephropathy and reverses the renalase reduction: potential role of renalase in adriamycin nephropathyPengxun Han, Huili Sun, Yuanzhao Xu, et al.
International Journal of Clinical and Experimental Pathology|June 9, 2020
Combination of astragaloside IV and ACEi ameliorates renal injuries in db/db miceHongyue Zhan, Pengxun Han, Menghua Wang, et al.
American Journal of Translational Research|February 17, 2022
Combination therapy with artemether and enalapril improves type 1 diabetic nephropathy through enhancing antioxidant defenseYijun Chen, Wenci Weng, Haiyang Zhang, et al.
Scientific Reports|January 15, 2021
Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in micePengxun Han, Yuchun Cai, Yao Wang, et al.
Diabetes Research and Clinical Practice|August 7, 2018
Niclosamide ethanolamine improves kidney injury in db/db micePengxun Han, Hongyue Zhan, Mumin Shao, et al.
The Journal of International Medical Research|June 14, 2018
Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic miceGaofeng Song, Pengxun Han, Huili Sun, et al.
American Journal of Translational Research|October 12, 2020
Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr micePengxun Han, Wenci Weng, Yinghui Chen, et al.
Plos One|August 3, 2017
Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control networkXinhui Liu, Wenjing Wang, Gaofeng Song, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Translational Research|July 18, 2019
Artemether improves type 1 diabetic kidney disease by regulating mitochondrial functionYao Wang, Pengxun Han, Menghua Wang, et al.
Plos One|April 29, 2026
Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolismQike Fu, Jiaxin Li, Xiufen Gu, et al.
Kidney & Blood Pressure Research|September 12, 2013
Lisinopril protects against the adriamycin nephropathy and reverses the renalase reduction: potential role of renalase in adriamycin nephropathyPengxun Han, Huili Sun, Yuanzhao Xu, et al.
International Journal of Clinical and Experimental Pathology|June 9, 2020
Combination of astragaloside IV and ACEi ameliorates renal injuries in db/db miceHongyue Zhan, Pengxun Han, Menghua Wang, et al.
American Journal of Translational Research|February 17, 2022
Combination therapy with artemether and enalapril improves type 1 diabetic nephropathy through enhancing antioxidant defenseYijun Chen, Wenci Weng, Haiyang Zhang, et al.
Scientific Reports|January 15, 2021
Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in micePengxun Han, Yuchun Cai, Yao Wang, et al.
Diabetes Research and Clinical Practice|August 7, 2018
Niclosamide ethanolamine improves kidney injury in db/db micePengxun Han, Hongyue Zhan, Mumin Shao, et al.
The Journal of International Medical Research|June 14, 2018
Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic miceGaofeng Song, Pengxun Han, Huili Sun, et al.
American Journal of Translational Research|October 12, 2020
Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr micePengxun Han, Wenci Weng, Yinghui Chen, et al.
Plos One|August 3, 2017
Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control networkXinhui Liu, Wenjing Wang, Gaofeng Song, et al.
Pageof 3